葛兰素史克 GSK 深 沪
等待开盘 01-09 09:30:00 美东时间
50.22
-0.400
-0.79%
华盛通- 最 高51.265
- 今 开50.80
- 成交量 440.70万股
- 最 低 50.02
- 昨 收 50.62
- 总市值 1008.42亿
- 52周最高 51.46
- 市盈率 静 31.61
- 换手率 0.00%
- 52周最低 31.1047
- 委 比 -46.62%
- 总股本 20.08亿
- 历史最高 51.46
- 量 比 1.03
- 振 幅 2.46%
- 历史最低 9.4472
- 每 手 1
- 风险率 4.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股机会日报 | 1.5万亿美元预算“大蛋糕”来袭！美股国防巨头盘前集体狂欢；阿里巴巴坚定加大投入淘宝闪购
1.5万亿美元预算“大蛋糕”来袭！美股国防巨头盘前集体狂欢，洛克希德马丁涨8%；脑机接口概念获热炒！脑再生科技盘前再涨13%；阿里坚定加大投入淘宝闪购>>
01-08 21:11
告别终身服药？乙肝患者有望迎来“功能性治愈”时代
英国制药公司葛兰素史克（GSK）宣布在研慢性乙肝疗法Bepirovirsen在两项关键三期临床试验中均达到主要终点。如果该药物获批，将意味着全球首个仅需6个月有...
01-08 17:24
“专利悬崖”大限将至 制药行业或迎来新一轮资产争夺战
①全球多款畅销药面临专利保护到期，预计到2032年将给制药巨头造成至少1739亿美元的年销售额损失； ②为填补收入缺口，制药公司正通过并购、合作、授权等方式获取新药或创新成果，预计2026年并购活动可能进一步升温。
01-07 21:57
葛兰素史克(GSK.US)慢性乙肝疗法达主要终点 或冲击20亿英镑峰值销售
全球超过2.5亿人受该疾病影响，葛兰素史克研究的重大成功使得功能性治愈更进一步;新药或助葛兰素史克实现雄心勃勃的营收目标。
01-07 19:44
Barclays Downgrades GSK to Underweight
Barclays analyst James Gordon downgrades GSK (NYSE:GSK) from Equal-Weight to Underweight.
01-07 03:51
盘前：纳指期货涨0.1% 资金加速从美股轮动至区域股市
周二全球股市在新年开局延续涨势，投资者正加速从美国市场轮动至区域股市，原因在于这些市场估值更具吸引力、增长前景更强。交易员在本周多项关键数据公布前仍保持乐观...
01-06 21:30
美股机会日报 | “英伟达合作伙伴”概念股盘前大涨！AMD苏姿丰称4年内AI芯片性能有望提升千倍
“英伟达合作伙伴”概念股盘前大涨！AEVA升逾24%，ARBE涨近14%；AMD苏姿丰称4年内AI芯片性能有望提升千倍；白银反弹，铜价续创历史新高！金田盘前涨逾3%>>
01-06 21:23
US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And GSK
In a move that could impact vaccine-makers like Merck & Co. Inc. (NYSE: MRK), GSK plc (NYSE: GSK), the U.S. government has decided to massively reduce the number of vaccines it recommends for every child.
01-06 21:16
公司简介
公司名称
|
葛兰素史克
|
行业分类
|
制药
|
业务描述
|
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
|
美股机会日报 | 1.5万亿美元预算“大蛋糕”来袭！美股国防巨头盘前集体狂欢；阿里巴巴坚定加大投入淘宝闪购
1.5万亿美元预算“大蛋糕”来袭！美股国防巨头盘前集体狂欢，洛克希德马丁涨8%；脑机接口概念获热炒！脑再生科技盘前再涨13%；阿里坚定加大投入淘宝闪购>>
01-08 21:11
告别终身服药？乙肝患者有望迎来“功能性治愈”时代
英国制药公司葛兰素史克（GSK）宣布在研慢性乙肝疗法Bepirovirsen在两项关键三期临床试验中均达到主要终点。如果该药物获批，将意味着全球首个仅需6个月有...
01-08 17:24
“专利悬崖”大限将至 制药行业或迎来新一轮资产争夺战
①全球多款畅销药面临专利保护到期，预计到2032年将给制药巨头造成至少1739亿美元的年销售额损失； ②为填补收入缺口，制药公司正通过并购、合作、授权等方式获取新药或创新成果，预计2026年并购活动可能进一步升温。
01-07 21:57
葛兰素史克(GSK.US)慢性乙肝疗法达主要终点 或冲击20亿英镑峰值销售
全球超过2.5亿人受该疾病影响，葛兰素史克研究的重大成功使得功能性治愈更进一步;新药或助葛兰素史克实现雄心勃勃的营收目标。
01-07 19:44
Barclays Downgrades GSK to Underweight
Barclays analyst James Gordon downgrades GSK (NYSE:GSK) from Equal-Weight to Underweight.
01-07 03:51
盘前：纳指期货涨0.1% 资金加速从美股轮动至区域股市
周二全球股市在新年开局延续涨势，投资者正加速从美国市场轮动至区域股市，原因在于这些市场估值更具吸引力、增长前景更强。交易员在本周多项关键数据公布前仍保持乐观...
01-06 21:30
美股机会日报 | “英伟达合作伙伴”概念股盘前大涨！AMD苏姿丰称4年内AI芯片性能有望提升千倍
“英伟达合作伙伴”概念股盘前大涨！AEVA升逾24%，ARBE涨近14%；AMD苏姿丰称4年内AI芯片性能有望提升千倍；白银反弹，铜价续创历史新高！金田盘前涨逾3%>>
01-06 21:23
US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And GSK
In a move that could impact vaccine-makers like Merck & Co. Inc. (NYSE: MRK), GSK plc (NYSE: GSK), the U.S. government has decided to massively reduce the number of vaccines it recommends for every child.
01-06 21:16
派息除权日
|
每股总股息
| 派息日期 |
2025-11-14
|
0.41
|
2026-01-08
|
2025-08-15
|
0.42
|
2025-10-09
|
2025-05-16
|
0.42
|
2025-07-10
|
2025-02-21
|
0.39
|
2025-04-10
|
2024-11-15
|
0.38
|
2025-01-09
|
2024-08-16
|
0.38
|
2024-10-10
|
2024-05-16
|
0.37
|
2024-07-11
|
2024-02-22
|
0.40
|
2024-04-11
|
2023-11-16
|
0.33
|
2024-01-11
|
2023-08-17
|
0.35
|
2023-10-12
|
2023-05-18
|
0.34
|
2023-07-13
|
2023-02-23
|
0.33
|
2023-04-13
|
2022-11-17
|
0.31
|
2023-01-12
|
2022-08-18
|
0.38
|
2022-10-06
|
2022-05-19
|
0.34
|
2022-07-01
|
2022-02-24
|
0.61
|
2022-04-07
|
2021-11-18
|
0.52
|
2022-01-13
|
2021-08-19
|
0.52
|
2021-10-07
|
2021-05-20
|
0.52
|
2021-07-08
|
2021-02-18
|
0.62
|
2021-04-08
|
2020-11-12
|
0.49
|
2021-01-14
|
2020-08-13
|
0.48
|
2020-10-08
|
2020-05-14
|
0.46
|
2020-07-09
|
2020-02-20
|
0.59
|
2020-04-09
|
2019-11-14
|
0.48
|
2020-01-09
|
2019-08-08
|
0.46
|
2019-10-10
|
2019-05-16
|
0.47
|
2019-07-11
|
2019-02-21
|
0.59
|
2019-04-11
|
2018-11-15
|
0.48
|
2019-01-10
|
2018-08-09
|
0.49
|
2018-10-11
|
2018-05-10
|
0.50
|
2018-07-12
|
2018-02-22
|
0.65
|
2018-04-12
|
2017-11-09
|
0.51
|
2018-01-11
|
2017-08-09
|
0.50
|
2017-10-12
|
2017-05-10
|
0.49
|
2017-07-13
|
2017-02-22
|
0.57
|
2017-04-13
|
2016-11-02
|
0.46
|
2017-01-12
|
2016-08-10
|
0.46
|
2016-10-13
|
2016-05-11
|
0.50
|
2016-07-14
|
2016-02-17
|
1.22
|
2016-04-14
|
2015-11-10
|
0.54
|
2016-01-14
|
2015-08-12
|
0.57
|
2015-10-01
|
2015-05-13
|
0.58
|
2015-07-09
|
2015-02-18
|
0.70
|
2015-04-09
|
2014-11-05
|
0.61
|
2015-01-08
|
2014-08-06
|
0.65
|
2014-10-02
|
2014-05-14
|
0.64
|
2014-07-10
|
2014-02-19
|
0.75
|
2014-04-10
|
2013-11-13
|
0.62
|
2014-01-09
|
2013-08-07
|
0.55
|
2013-10-03
|
2013-05-08
|
0.55
|
2013-07-11
|
2013-02-20
|
0.69
|
2013-04-11
|
2012-11-14
|
0.58
|
2013-01-03
|
2012-08-08
|
0.53
|
2012-10-04
|
2012-05-09
|
0.55
|
2012-07-05
|
2012-02-15
|
0.82
|
2012-04-12
|
2011-11-02
|
0.54
|
2012-01-05
|
2011-08-03
|
0.52
|
2011-10-06
|
2011-05-04
|
0.53
|
2011-07-07
|
2011-02-09
|
0.62
|
2011-04-07
|
2010-10-27
|
0.51
|
2011-01-06
|
2010-07-28
|
0.46
|
2010-10-07
|
2010-05-05
|
0.46
|
2010-07-08
|
2010-02-10
|
0.57
|
2010-04-08
|
2009-11-04
|
0.49
|
2010-01-07
|
2009-07-29
|
0.46
|
2009-10-08
|
2009-04-29
|
0.41
|
2009-07-09
|
2009-02-11
|
0.49
|
2009-04-09
|
2008-10-29
|
0.47
|
2009-01-08
|
2008-07-30
|
0.52
|
2008-10-09
|
2008-04-30
|
0.52
|
2008-07-10
|
2008-02-13
|
0.63
|
2008-04-10
|
2007-10-31
|
0.53
|
2008-01-10
|
2007-08-01
|
0.49
|
2007-10-11
|
2007-05-02
|
0.48
|
2007-07-12
|
2007-02-14
|
0.55
|
2007-04-12
|
2006-11-01
|
0.45
|
2007-01-04
|
2006-08-02
|
0.41
|
2006-10-05
|
2006-05-10
|
0.39
|
2006-07-06
|
2006-02-15
|
0.49
|
2006-04-06
|
2005-11-02
|
0.36
|
2006-01-05
|
2005-08-03
|
0.35
|
2005-10-06
|
2005-05-11
|
0.38
|
2005-07-07
|
2005-02-16
|
0.44
|
2005-04-07
|
2004-11-03
|
0.37
|
2005-01-06
|
2004-08-04
|
0.37
|
2004-09-30
|
2004-05-12
|
0.35
|
2004-07-01
|
2004-02-18
|
0.52
|
2004-04-15
|
2003-10-29
|
0.30
|
2004-01-06
|
2003-07-30
|
0.29
|
2003-10-02
|
2003-05-07
|
0.29
|
2003-07-03
|
2003-02-19
|
0.42
|
2003-04-17
|
2002-10-30
|
0.28
|
2003-01-03
|
2002-07-31
|
0.28
|
2002-10-03
|
2002-05-01
|
0.26
|
2002-07-05
|
2002-02-20
|
0.34
|
2002-04-18
|
2001-10-31
|
0.26
|
2002-01-03
|
2001-08-01
|
0.25
|
2001-10-04
|
2001-05-02
|
0.26
|
2001-07-05
|
2000-12-27
|
0.66
|
2001-04-27
|
2000-08-09
|
0.43
|
2000-10-26
|
2000-03-01
|
0.65
|
2000-06-05
|
1999-08-11
|
0.49
|
1999-10-12
|
1999-03-03
|
0.68
|
1999-06-01
|
1998-08-12
|
0.51
|
1998-10-13
|
1998-03-04
|
0.65
|
1998-06-01
|
1997-08-13
|
0.48
|
1997-10-13
|
1997-03-19
|
0.50
|
1997-05-30
|
1996-08-16
|
0.50
|
1996-10-11
|
1996-03-22
|
0.48
|
1996-05-30
|
1995-09-22
|
0.67
|
1995-11-02
|
1995-02-24
|
0.34
|
1995-04-20
|
1994-09-23
|
0.60
|
1994-12-01
|
1994-03-14
|
0.28
|
1994-04-21
|
1993-09-24
|
0.47
|
1993-11-29
|
1993-03-05
|
0.23
|
1993-05-10
|
1992-09-21
|
0.38
|
1992-11-23
|
1992-02-28
|
0.24
|
1992-05-11
|
1982-05-12
|
0.09
|
1982-07-06
|
1981-11-20
|
0.16
|
1982-01-19
|
1981-05-18
|
0.08
|
1981-07-03
|
1980-11-21
|
0.17
|
1981-01-19
|
